Sagimet Biosciences, Inc. Class A Financial Overview
Sagimet Biosciences, Inc. Class A's market cap is currently $194.38M. The company's EPS TTM is $-0.4; its P/E ratio is ―; Sagimet Biosciences, Inc. Class A is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.42. See an overview of income statement, balance sheet, and cash flow financials.
